Article Details
Retrieved on: 2023-10-27 22:10:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Esophageal Cancer. According to GlobalData, Phase II drugs ...
Article found on: www.pharmaceutical-technology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here